These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 13334092)

  • 41. Oxytetracycline-hydrocortisone ointment in dermatological therapy.
    SHAPIRO SI
    Ariz Med; 1955 Sep; 12(9):406-8. PubMed ID: 13260005
    [No Abstract]   [Full Text] [Related]  

  • 42. Hydrocortisone with neomycin ointment in dermatologic therapy; a clinical study.
    SOFEN MB
    J Mich State Med Soc; 1954 Dec; 53(12):1351-2. PubMed ID: 13222125
    [No Abstract]   [Full Text] [Related]  

  • 43. Hydrocortisone (compound F) acetate ointment in dermatological therapy.
    SULZBERGER MB; WITTEN VH; SMITH CC
    J Am Med Assoc; 1953 Feb; 151(6):468-72. PubMed ID: 13011029
    [No Abstract]   [Full Text] [Related]  

  • 44. Hydrocortisone in therapy of cutaneous disease; preliminary report.
    HEILESEN B; KRISTJANSEN A; REYMANN F
    AMA Arch Derm Syphilol; 1954 Sep; 70(3):360-2. PubMed ID: 13188473
    [No Abstract]   [Full Text] [Related]  

  • 45. Hydrocortisone (compound F) free alcohol ointment.
    SULZBERGER MB; WITTEN VH; SMITH CC
    J Am Med Assoc; 1953 Aug; 152(15):1456. PubMed ID: 13061305
    [No Abstract]   [Full Text] [Related]  

  • 46. Vioform and hydrocortisone in dermatologic therapy.
    ALLISON SD
    Am Pract Dig Treat; 1956 Jul; 7(7):1119-20. PubMed ID: 13327202
    [No Abstract]   [Full Text] [Related]  

  • 47. Clinical evaluation of five-tenths per cent hydrocortisone ointment.
    FRANK L; STRITZLER C; KAUFMAN J
    AMA Arch Derm; 1955 May; 71(5):637-8. PubMed ID: 14360793
    [No Abstract]   [Full Text] [Related]  

  • 48. Local intralesional injection of hydrocortisone with cartridge type of syringe.
    GOLDMAN L; PRESTON RH; BASKETT J
    AMA Arch Derm; 1955 Feb; 71(2):157. PubMed ID: 13227605
    [No Abstract]   [Full Text] [Related]  

  • 49. Fungating iododerma treated with hydrocortisone.
    AQUILINA JT; BISSELL GW
    J Am Med Assoc; 1955 Jul; 158(9):727-30. PubMed ID: 14381247
    [No Abstract]   [Full Text] [Related]  

  • 50. An appraisal of compound F (hydrocortisone acetate)-neomycin ointment in clinical dermatology.
    FALK MS
    Acta Derm Venereol; 1955; 35(2):132-42. PubMed ID: 13248419
    [No Abstract]   [Full Text] [Related]  

  • 51. Topical hydrocortisone-oxytetracycline therapy.
    STRITZLER C; FRANK L
    AMA Arch Derm; 1955 Jun; 71(6):736-9. PubMed ID: 14375396
    [No Abstract]   [Full Text] [Related]  

  • 52. Failure of a local inhibitory action on local injection of the free alcohol of compound F (hydrocortisone) in some dermatologic lesions.
    GOLDMAN L; O'HARA H; EMURA E; BASKETT J
    J Invest Dermatol; 1952 Oct; 19(4):267-8. PubMed ID: 12990832
    [No Abstract]   [Full Text] [Related]  

  • 53. [Topical activity of cortisone, hydrocortisone and its derivative 9 alpha-fluorohydrocortisone acetate; progressive study of 285 cases and comparative evaluation of the clinical results].
    MOM AM; WAISSBEIN BD
    Prensa Med Argent; 1955 May; 42(19):1356-62. PubMed ID: 13245688
    [No Abstract]   [Full Text] [Related]  

  • 54. The present status of the use of corticotropin, cortisone, hydrocortisone, and prednisone in dermatology.
    CANIZARES O; SHATIN H; ROSENBAUM HM
    N Y State J Med; 1955 Dec; 55(24):3583-90. PubMed ID: 13272903
    [No Abstract]   [Full Text] [Related]  

  • 55. Studies of 11-alpha hydrocortisone in the chick embryo and on skin lesions in man.
    KARNOFSKY DA; SULLIVAN RD; ROSS C; RODDY J
    Proc Soc Exp Biol Med; 1953 Oct; 84(1):159-62. PubMed ID: 13120971
    [No Abstract]   [Full Text] [Related]  

  • 56. On the adrenal cortical steroids in relation to allergic dermatoses.
    SULZBERGER MB
    N Y State J Med; 1956 Jun; 56(11):1827-31. PubMed ID: 13322280
    [No Abstract]   [Full Text] [Related]  

  • 57. [Studies on adrenal function in dermatology. I. Preliminary observations on the urinary elimination of 11-oxycorticoids in dermatoses].
    SEMMOLA L; PANCONESI E
    Rass Dermatol Sifilogr; 1951; 4(3):168-79. PubMed ID: 14912460
    [No Abstract]   [Full Text] [Related]  

  • 58. The treatment of resistant dermatoses with panto-F.
    O'BRASKY L
    Conn State Med J; 1956 Aug; 20(8):633-6. PubMed ID: 13343827
    [No Abstract]   [Full Text] [Related]  

  • 59. [Investigation into adrenal atrophy induced by anti-inflammatory hormones (cortisone, hydrocortisone and metacortandracine)].
    COSTE F; DELBARRE F; BASSET G
    Sem Hop; 1955 Aug 26-30; 31(50-51):2713-6. PubMed ID: 13267476
    [No Abstract]   [Full Text] [Related]  

  • 60. [Skin grafts and hydrocortisone].
    CRISPOUX J
    Presse Med (1893); 1955 Nov; 63(73):1503. PubMed ID: 13280681
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.